Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy.
about
Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapyRoles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsDeregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.Integrin-linked kinase regulates cadherin switch in bladder cancer.Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma.Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer.The therapeutic potential of mTOR inhibitors in breast cancer.Quantitative phosphoproteome analysis of embryonic stem cell differentiation toward bloodShenLingLan Influences the Attachment and Migration of Ovarian Cancer Cells Potentially through the GSK3 Pathway.Exposure to a 50-Hz magnetic field induced mitochondrial permeability transition through the ROS/GSK-3β signaling pathway.Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die.Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression.Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro.Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth.Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancerResibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3
P2860
Q26739711-97835B4C-2053-4934-87E0-0F397BA7C15DQ28072650-D1B0C881-DFFE-49A2-A0BA-B178A75D1630Q34103963-7F3366CA-682F-4E1A-8F0F-65CCF62D8243Q36019650-B8AC14B9-C904-4F3A-8809-DEA08A56AE4FQ36069860-7E768B6B-B0F1-4C86-82C1-EB37112E0E41Q37447588-435E447A-C6FC-406D-91DB-312034377C3BQ38721782-A9AD0A85-1B1F-4495-B2BD-030538853C5FQ38756542-3D23F12D-97A1-4B48-92BE-057ED4FAFE3DQ38774498-22D73703-9AFF-4E0A-825A-48C32E76C126Q38802412-100C50A6-34C1-4DE3-89BB-32B98955E8D0Q38885106-A20E2E63-CFC3-483B-96CE-F58DD734213EQ41146125-A7711131-3724-4C07-A130-8E0FB42C0F96Q46599756-F802932C-E3B3-4B6F-A0DB-23B2F0464B01Q47168387-D0B07544-3A20-4BDE-979D-29161B6C23F7Q49882954-A9781E7A-203D-4BCE-9F51-F4F2FC5BBEE2Q54110507-A1A8C5B5-B2D1-4730-9137-1D1C50F98AFAQ54302548-AE28886B-ED41-4666-9907-28E1E98243FAQ57107973-1CA4766F-EEE6-4479-8846-1A9867FD394EQ58701699-27654F28-A5FE-4F7B-8877-9A358147A818
P2860
Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy.
@en
type
label
Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy.
@en
prefLabel
Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy.
@en
P2093
P50
P1476
Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy.
@en
P2093
Alberto M Martelli
Ferdinando Nicoletti
Linda S Steelman
Lucio Cocco
Nicole M Davis
Stephen L Abrams
P304
P356
10.1016/J.JBIOR.2013.09.013
P577
2013-10-08T00:00:00Z